Aurinia Pharmaceuticals Inc (AUPH)

Cost of Revenue

$30.04M

TTM · Period ending: · USD

AUPH logo

AUPH Cost of Revenue

Latest reported$30.04M
AUPH TTM Cost of Revenue ($678.44K → $30.04M)
High-resolution chart · PNG

AUPH cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
30,036,000
30,596,000
32,665,000
29,745,000
27,276,000
29,070,000
28,248,000
28,091,000
28,825,000
21,479,000
14,148,000
10,115,000
5,793,000
5,829,000
5,664,000
4,783,000
2,590,000
1,299,000
1,091,000
610,000
356,000
48,000
0
13,292,000
31,083,000
42,235,000
52,866,000
50,413,000
43,774,000
43,126,000
41,382,000
39,234,000
38,889,000
35,492,000
26,606,000
17,916,000
7,110,000
4,000
4,000
5,000
5,000
8,000
12,000
18,000
28,000
34,000
37,000
29,939
542,939
974,939
967,922
973,598
458,742
27,557
45,617
52,581
55,001
59,673
195,994
191,732
188,891
178,147
50,250
79,808
115,990
348,121
320,654
125,892
1,887,146
1,877,232
2,130,802
2,656,980
1,138,895
1,075,392
821,822
616,980
487,422
452,308
452,308
286,859
128,343
0
0
0
0
0
0
0
0
0
0
117,664
311,734
550,441
685,245
737,294
919,804
970,052
1,052,865
1,080,726
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.